Return to Chelation Therapy page
Case Study - Kidney function improves with chelation - RT
I began working with RT in August of 2006. RT was 64 years old. Hypertension had been present for several years, and was being treated with Lisinopril 10 mg (an angiotensin converting enzyme inhibitor) and hydrochlorothiazide (HCTZ, a thiazide diuretic). His creatinine (laboratory index of kidney function - normal is ≤ 1.3 mg/dl) was elevated at 1.5 mg/dl. Our evaluation included a kidney ultrasound study, which returned normal, and a triple challenge study, which demonstrated a significant Lead spill.
We know from the literature that Lead, even "normal" levels of Lead, is associated with kidney dysfunction and hypertension, so it made sense to me to treat RT with EDTA chelation. RT received 20 Mg-EDTA infusions, and what do you know, his blood pressure normalized, such that drug therapy could be stopped, his creatinine returned to normal at 1.3 mg/dl, and his post-triple challenge Lead spill decreased.
I know, I know, chelation therapy is considered to be "Alternative Medicine", but Lead detoxification as an alternative to drugs and kidney dysfunction is an alternative that I can live with. RT's positive result is anything but a surprise. Two randomized, double blind, placebo controlled trials of EDTA chelation in patients with moderate kidney disease have demonstrated a profound protective effect (see Lead in Medical Topics section). These papers were published in the New England Journal of Medicine and in Archives of Internal Medicine. The positive results have been ignored by the medical community and by health insurers. I wonder why?
Case Study - Kidney function improves with chelation - FG
I began working with FG in May of 2007 This 51 year old, physically active, health aware non-smoker presented with several non-cardiac conditions. FG's amalgam fillings had been removed 1-2 years earlier and he had been sleeping on a negative field only sleep pad. FG's blood pressure was normal, but his serum creatinine returned elevated at 1.4 mg/dl. A renal ultrasound returned normal, while FG's triple challenge study demonstrated relatively unimpressive spills of Lead, Mercury, Aluminum, and Arsenic.
Asparagus extract was added to FG's already extensive nutritional program, and Mg-EDTA chelation therapy initiated. Following approximately 15 treatments, FG's creatinine was down to 1.1 mg/dl, and a repeat triple challenge study demonstrated reduced metal spills (tungsten was now beginning to come out, as the toxins to which EDTA binds more avidly had drained down).
FG was no where near dialysis, but it certainly appears that his metal burden was beginning to get the best of his kidneys. Simple, low cost chealtion therapy removed this toxic burden on FG's kidneys, and his creatinine normalized. Drugs can't do this, invasive procedures can't do this, but "getting the Lead out" did..